Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Oh, Hyun-A | - |
dc.contributor.author | Kim, Donghak | - |
dc.contributor.author | Lee, Soo Hyun | - |
dc.contributor.author | Jung, Byung Hwa | - |
dc.date.accessioned | 2024-01-20T07:31:53Z | - |
dc.date.available | 2024-01-20T07:31:53Z | - |
dc.date.created | 2021-09-05 | - |
dc.date.issued | 2015-03-25 | - |
dc.identifier.issn | 0731-7085 | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/125644 | - |
dc.description.abstract | A simple and rapid quantitative analytical method for the simultaneous detection of celecoxib and its two main metabolites, hydroxycelecoxib (celecoxib-OH) and celecoxib carboxylic acid (celecoxib-COOH), in rat plasma using liquid chromatography-tandem mass spectrometry (LC-MS/MS) was developed. The plasma sample was prepared through simple protein precipitation, and the reconstitution solution (0.1% formic acid in 50% methanol) was optimized to achieve the best peak shape and recovery. The analytes were separated using an Atlantis T3 column (2.1 mm x 100 mm, 3 mu m), and the mobile phase was composed of 10 mM ammonium formate in either 5% acetonitrile or 95% acetonitrile. The detection of the analytes was performed in alternating polarity switching mode using electrospray ionization. As celecoxib-OH and celecoxib-COOH were slightly unstable following freeze-thaw cycles and long-term storage at -80 degrees C in stability tests, every analysis was carefully conducted with one-freeze thaw cycle and a short storage duration (<1 week). Acceptable accuracy (<15%) and precision (<15%) were obtained in intra- and inter-day validations. The method was successfully applied to the pharmacokinetic study of celecoxib, celecoxib-OH and celecoxib-COOH following the oral administration of celecoxib in rats at a dose of 10 mg/kg. Comparing the related pharmacokinetic parameters of celecoxib and its metabolites, celecoxib was quickly metabolized into celecoxib-OH and subsequently converted to celecoxib-COOH in short intervals. The AUCs for the two metabolites were less than 10% of that for celecoxib, indicating that the rate of celecoxib metabolism was low. (C) 2014 Elsevier B.V. All rights reserved. | - |
dc.language | English | - |
dc.publisher | ELSEVIER SCIENCE BV | - |
dc.subject | HUMAN PLASMA | - |
dc.subject | CLINICAL PHARMACOKINETICS | - |
dc.subject | COLORECTAL ADENOMA | - |
dc.subject | COX-2 INHIBITORS | - |
dc.subject | PREVENTION | - |
dc.subject | EXCRETION | - |
dc.subject | DISEASE | - |
dc.subject | TISSUE | - |
dc.subject | MS/MS | - |
dc.title | Simultaneous quantitative determination of celecoxib and its two metabolites using liquid chromatography-tandem mass spectrometry in alternating polarity switching mode | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.jpba.2014.12.004 | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, v.107, pp.32 - 39 | - |
dc.citation.title | JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS | - |
dc.citation.volume | 107 | - |
dc.citation.startPage | 32 | - |
dc.citation.endPage | 39 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.identifier.wosid | 000351116900006 | - |
dc.identifier.scopusid | 2-s2.0-84921303193 | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Analytical | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | HUMAN PLASMA | - |
dc.subject.keywordPlus | CLINICAL PHARMACOKINETICS | - |
dc.subject.keywordPlus | COLORECTAL ADENOMA | - |
dc.subject.keywordPlus | COX-2 INHIBITORS | - |
dc.subject.keywordPlus | PREVENTION | - |
dc.subject.keywordPlus | EXCRETION | - |
dc.subject.keywordPlus | DISEASE | - |
dc.subject.keywordPlus | TISSUE | - |
dc.subject.keywordPlus | MS/MS | - |
dc.subject.keywordAuthor | Celecoxib | - |
dc.subject.keywordAuthor | Celecoxib metabolites | - |
dc.subject.keywordAuthor | Quantitation | - |
dc.subject.keywordAuthor | Liquid chromatography-tandem mass spectrometry | - |
dc.subject.keywordAuthor | Alternating polarity switching | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.